Prof. Konrad Rejdak graduated from the Medical University of Lublin (Poland). Prof. Konrad Rejdak trained clinical neurology in Lublin (Poland) and had clinical attachments in Erlangen (Germany) and London (UK). His main research and clinical interest include multiple sclerosis and other inflammatory diseases. Other interests include biomarker discovery and advanced technology devices development for neurological patients. He was trained in clinical biochemistry at the Department of Neuroinflammation, Institute of Neurology, UCL in London (UK). He performed several projects relating to the markers of inflammatory and neurodegenerative processes in the course of neurological diseases, publishing the results in international peer-reviewed journals. Currently, Prof. Konrad Rejdak is a consultant neurologists and head of the Department of Neurology, Medical University of Lublin (Poland). He is a member of the executive committee and president of the Polish Neurological Society (2021-2024).
